1-3 of 3
Dawn C. Schwenke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans

Juraj Koska, Michelle Sands, Camelia Burciu, Karen M. D’Souza, Kalyani Raravikar, James Liu, Seth Truran, Daniel A. Franco, Eric A. Schwartz, Dawn C. Schwenke, David D’Alessio, Raymond Q. Migrino, Peter D. Reaven
Journal: Diabetes
Diabetes 2015;64(7):2624–2635
https://doi.org/10.2337/db14-0976
Published: 26 February 2015
View articletitled, Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
Open the PDF for Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans in another window
Includes: Supplementary data
Journal Articles

Prevention of Diabetes With Pioglitazone in ACT NOW: Physiologic Correlates

Ralph A. DeFronzo, Devjit Tripathy, Dawn C. Schwenke, MaryAnn Banerji, George A. Bray, Thomas A. Buchanan, Stephen C. Clement, Amalia Gastaldelli, Robert R. Henry, Abbas E. Kitabchi, Sunder Mudaliar, Robert E. Ratner, Frankie B. Stentz, Nicolas Musi, Peter D. Reaven, for the ACT NOW Study
Journal: Diabetes
Diabetes 2013;62(11):3920–3926
https://doi.org/10.2337/db13-0265
Published: 18 October 2013
View articletitled, Prevention of Diabetes With Pioglitazone in ACT NOW: Physiologic Correlates
Open the PDF for Prevention of Diabetes With Pioglitazone in ACT NOW: Physiologic Correlates in another window
Includes: Supplementary data
Journal Articles

Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis

Peter D. Reaven, Thomas E. Moritz, Dawn C. Schwenke, Robert J. Anderson, Michael Criqui, Robert Detrano, Nicholas Emanuele, Moti Kayshap, Jennifer Marks, Sunder Mudaliar, R. Harsha Rao, Jayendra H. Shah, Steven Goldman, Domenic J. Reda, Madeline McCarren, Carlos Abraira, William Duckworth, for the Veterans Affairs Diabetes Trial
Journal: Diabetes
Diabetes 2009;58(11):2642–2648
https://doi.org/10.2337/db09-0618
Published: 03 August 2009
View articletitled, Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
Open the PDF for Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis in another window
Includes: Supplementary data